Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab

Transplantation Proceedings

Volumn 36, Issue 10, 2004, Pages 3164-3166

  Baran, David A ^a   Lubitz, S ^b   Alvi, S ^a   Fallon, J T ^b   Kaplan, S ^b   Galin, I ^b   Correa, R ^b   Courtney, M C ^b   Chan, M ^b   Spielvogel, D ^b   Lansman, S L ^b   Gass, A L ^b  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MILRINONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RITUXIMAB; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CARDIAC GRAFT REJECTION; CASE REPORT; DRUG DOSE REGIMEN; GRAFT SURVIVAL; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SWAN GANZ CATHETER; ALLOTRANSPLANTATION; ANTIBODY PRODUCTION; CONGESTIVE CARDIOMYOPATHY; DRUG EFFECT; GRAFT REJECTION; IMMUNOLOGY; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTILYMPHOCYTE SERUM; CARDIOMYOPATHY, DILATED; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 21244479438     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.087     Document Type: Article

References (15)

1. Michaels PJ, Espejo ML, Kobashigawa J, et al: Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22:58, 2003
2. Cheson BD: Hematologic malignancies: new developments and future treatments. Semin Oncol 29:33, 2002
3. Dillman RO: Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma. J Clin Oncol 20:3545, 2002
4. Skoda-Smith S, Douglas VK, Mehta P, et al: Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. Bone Marrow Transplant 27:329, 2001
5. Zilz ND, Olson LJ, McGregor CG: Treatment of post-transplant lymphoproliferative disorder with monoclonal CD20 antibody (rituximab) after heart transplantation. J Heart Lung Transplant 20:770, 2001
6. Cook RC, Connors JM, Gascoyne RD, et al: Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation. Lancet 354:1698, 1999
7. Pham PT, Wilkinson AH, Gritsch HA, et al: Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease. Transplant Proc 34:1178, 2002
8. Aranda JM Jr, Scornik JC, Normann SJ, et al: Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 73:907, 2002
9. Hammond EH, Yowell RL, Nunoda S, et al: Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 8:430, 1989
10. Grauhan O, Muller J, v Baeyer H, et al: Treatment of humoral rejection after heart transplantation. J Heart Lung Transplant 17:1184, 1998
11. Grauhan O, Knosalla C, Ewert R, et al: Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. J Heart Lung Transplant 20:316, 2001
12. Montgomery RA, Zachary AA, Racusen LC, et al: Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70:887, 2000
13. Jordan SC, Quartel AW, Czer LS, et al: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 66:800, 1998
14. Malafa M, Mancini MC, Myles JL, et al: Successful treatment of acute humoral rejection in a heart transplant patient. J Heart Lung Transplant 11:486, 1992
15. McManus RP, Kinney T, Komorowski R, et al: Reversibility of cardiac xenograft rejection in primates. J Heart Lung Transplant 10:567, 1991